Cantor Fitzgerald Reiterates Overweight on Progyny, Maintains $48 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Progyny (NASDAQ:PGNY) and maintained a $48 price target. This reaffirms the firm's positive outlook on the stock.
February 28, 2024 | 4:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Progyny, maintaining a $48 price target, indicating a positive outlook.
The reiteration of an Overweight rating and maintenance of a $48 price target by a reputable analyst firm like Cantor Fitzgerald suggests a strong belief in Progyny's future performance. This positive outlook is likely to influence investor sentiment and could lead to a short-term increase in PGNY's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100